Shares of Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report) traded up 14.1% on Tuesday . The stock traded as high as GBX 2.19 ($0.03) and last traded at GBX 2.17 ($0.03). 1,074,848 shares changed hands during trading, a decline of 33% from the average session volume of 1,601,397 shares. The stock had previously closed at GBX 1.90 ($0.02).
Cizzle Biotechnology Stock Performance
The firm has a market capitalization of £7.29 million, a PE ratio of -183.80 and a beta of 0.38. The company’s fifty day moving average price is GBX 1.79 and its two-hundred day moving average price is GBX 1.86.
About Cizzle Biotechnology
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021.
Featured Articles
- Five stocks we like better than Cizzle Biotechnology
- What Investors Need to Know to Beat the Market
- Vistra Corp: Could 2025 Continue Its Streak of Outperformance?
- The 3 Best Blue-Chip Stocks to Buy Now
- Vertex’s Pain Drug: Big Pharma’s Next Major Success?
- How to trade using analyst ratings
- D-Wave’s Stock Springs Back in the Quantum Computing Race
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
